ReviewClinical cardiology2011
Neoplastic pericardial effusion.
Review in Clinical cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 136 citations in OpenAlex.
- Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients.PloS one · 2018Trial
- Subacute normotensive cardiac tamponade as the initial presentation of metastatic lung adenocarcinoma: a case report.Journal of medical case reports · 2026Article
- Article
- Case Report: Cardiac angiosarcoma with rib pain as the first symptom.Frontiers in oncology · 2026Article
- Article
- Article
- Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature.Journal of cardiothoracic surgery · 2025Review
- Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.Cancers · 2024Review
- Malignant Pericardial Effusion: A Systematic Review.CJC open · 2024Review
- Article
- Pericardial effusion in oncological patients: current knowledge and principles of management.Cardio-oncology (London, England) · 2024Review
- Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine.Current issues in molecular biology · 2023Review
- Cardiac tamponade.Nature reviews. Disease primers · 2023Review
- Extramedullary Acute Myeloid Leukemia Presenting With Pericardial Effusion and Arrhythmias.Cureus · 2023Article
- Prevalence, characteristics and mortality of cancer patients undergoing pericardiocentesis in the United States between 2004 and 2017.Cancer medicine · 2023Article
- Incidence of malignant pericardial effusion in pericardiocentesis patients and post-procedure care: an oncology center pilot study.American journal of translational research · 2023Article
- Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer.Frontiers in oncology · 2023Article
- The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion.Anatolian journal of cardiology · 2023Article
- A case series of malignant pericardial effusion.Journal of family medicine and primary care · 2022Article
- Diagnosis, treatment, and management of pericardial effusion- review.Annals of medicine and surgery (2012) · 2022Review
Corrections and comments
- Commented on by
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neoplastic pericardial effusion is a serious and common clinical disorder encountered by cardiologists, cardiothoracic surgeons, oncologists, and radiation oncologists. It may develop from direct extension or metastatic spread of the underlying malignancy, from an opportunistic infection, or from a complication of radiation therapy or chemotherapeutic toxicity. The clinical presentation varies, and the patient may be hemodynamically unstable in the setting of constrictive pericarditis and cardiac tamponade. The management depends on the patient's prognosis and varies from pericardiocentesis, sclerotherapy, and balloon pericardiotomy to cardiothoracic surgery. Patients with neoplastic pericardial effusion face a grave prognosis, as their malignancy is usually more advanced. This review article discusses the epidemiology and etiology, pathophysiology, clinical presentation, diagnosis, management, and prognosis of neoplastic pericardial effusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.